Live Chat

Trade Bristol Myers BMY

Sell
 Buy

BristolMyers live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
date Close change Change (%) Open High Low

Latest news

Frances Wang 2024 Nov 20, 16:00

MicroStrategy Stock Surges as Bitcoin price rises to fresh record above $94K

Cryptocurrencies
Mixed market performance
Neil Wilson 2024 Nov 20, 16:00

Markets Mixed Amid Inflation, Tech Rally, and UK Economic Woes

USD Tech S&P 500
Frances Wang 2024 Nov 19, 16:00

Nvidia shares rallied on AI spending ahead of Nvidia Q3 earnings 2024

NVDA Stocks
Frances Wang 2024 Nov 19, 16:00

Bitcoin price hits record high over $93,800 as Trump rally resumes

Cryptocurrencies
Rising gold prices
Neil Wilson 2024 Nov 19, 16:00

Gold Shines, Bitcoin Surges, and Nvidia Earnings in Focus

Gold Cryptocurrencies
Frances Wang 2024 Nov 18, 16:00

What is the cryptocurrency market doing: Musk's DOGE Role Boosts Dogecoin

Cryptocurrencies
Frances Wang 2024 Nov 18, 16:00

Bitcoin price prediction: BTC May Reach $100K Before New Year

Cryptocurrencies
Frances Wang 2024 Nov 18, 16:00

25% upside, Nvidia stock (NVDA) has rocketed to all-time highs

Stocks

Info

Spread

0.35

Spread (%)

0.6063 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Thursday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

118100672512

Shares Outstanding

2028179968

Earnings Date (Next)

2001-08-07

instr__dividend_date

2024-11-01

instr__ex_dividend_date

2024-10-04

instr__forward_annual_dividend_rate

2.4

instr__forward_annual_dividend_yield

0.0412

EPS

-3.56

Learn more about this instrument

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments
Trustpilot
Live Chat